BRIEF-AstraZeneca CEO says "hard to comment" on whether Pfizer will return
November 18, 2014 at 04:59 AM EST
Nov 18 (Reuters) - AstraZeneca executives, speaking to reporters: * CEO says hard to comment on read-across from Pfizer/Merck cancer
